Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 53, Issue 7, 2008, Pages 457-464

  Cole, Laurence A ^a   Khanlian, Sarah A ^a   Muller, Carolyn Y ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Subunit; Human chorionic gonadotropin; Placenta; Trophoblastic neoplasm

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

BLOOD EXAMINATION; CLINICAL EVALUATION; CONFERENCE PAPER; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LABORATORY TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TROPHOBLASTIC TUMOR; TUMOR BIOPSY; TUMOR DIAGNOSIS;

CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; PREGNANCY; TROPHOBLASTIC TUMOR, PLACENTAL SITE; UTERINE NEOPLASMS;

EID: 48949096876     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Paradinas FJ, Sbire NJ, Rees HC: Pathology. In Gestational Trophoblastic Disease. Edited by BW Hancock, ES Newlands, RS Berkowitz, LA Cole. Sheffield, England, Sheffield University Press, 2003, pp 77-129
2. Fisher RA, Paradinas FJ, Newlands ES, et al: Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus. Br J Cancer 1992;65:355-358
3. Feltmate CM, Genest DR, Wise L, et al: Placental site trophoblastic tumor: A 17-year experience at the New England Trophoblastic Disease Center. Gynecol Oncol 2001;82:415-419
4. Papadopoulos AJ, Foskett M, Seckl MJ, et al: Twenty-five years clinical experience with placental site trophoblastic tumors. J Reprod Med 2002;47:460-464
5. Cole LA, Butler SA, Khanlian SA, et al: Gestational trophoblastic diseases: II. Hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol Oncol 2006;102:150-158
6. Kovaleskaya G, Genbacev O, Fisher SJ, et al: Trophoblast origin of hCG isoforms: Cytotrophoblasts are the primary source or choriocarcinoma-like hCG. Mol Cell Endocrinol 2002;194:147-155
7. Cole LA, Dai D, Leslie KK, et al: Gestational trophoblastic diseases: I. Pathophysiology of hyperglycosylated hCG-regulated neoplasia. Gynecol Oncol 2006;102:144-149
8. Rinne K, Shahabi S, Cole LA: Following metastatic placental site trophoblastic tumor with urine β-core fragment. Gynecol Oncol 1999;74:302-303
9. Cole LA, Khanlian SA, Muller CY, et al: Gestational trophoblastic diseases: III. Human chorionic gonadotropin free β-subunit a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 2006;102:159-163
10. Harvey RA: Is human chorionic gonadotrophin (hCG) free β-subunit measurment a specific marker of placental site trophoblastic tumors (PSTT). Abstract presented at the 14th World Congress on Gestational Trophoblastic Disease, Fukuoka, Japan, 2007, p 49
11. D'Agostino RS, Cole LA, Form RB, et al: Urinary gonadotropin fragment in patients with lung and esophageal disease. J Surg Oncol 1992;49:147-150
12. Cole LA, Tanaka A, Kim GS, et al: Beta core fragment (β-core/UGF/ UGP), a tumor marker: Seven year report. Gynecol Oncol 1996;60:264-270
13. Marcillac I, Toalen F, Bidart J-M, et al: Free human chorionic gonadotropin β-subunit in gonadal and nongonadal neoplasms. Cancer Res 1992;52:3901-3907
14. Alfhan H, Haglund C, Roberts P, et al: Elevation of free β-subunit of human choriogonadotropin and core β fragment of choriogonadotropin in serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 1992; 52:4628-4633
15. Cole LA, Sutton JM: Selecting an appropriate hCG test for management of gestational trophoblastic diseases and cancer cases. J Reprod Med 2004;49545-553
16. Cole LA, Sutton JM, Higgins TN, et al: Between-method variation in hCG test results. Clin Chem 2004;50:874-882
17. Khanlian SA, Smith HO, Cole LA: Persistent low levels of hCG: A pre-malignant gestational trophoblastic disease. Am J Obstet Gynecol 2003;188:1254-1259
18. Cole LA, Khanlian SA: Inappropriate management of women with persistent low hCG results. J Reprod Med 2004;49: 423-432
19. Cole LA, Khanlian SA, Giddings A, et al: Gestational trophoblastic diseases: IV. Presentation with persistent low positive human chorionic gonadotropin. Gynecol Oncol 2006;102:164-171
20. Rotmensch S, Cole LA: False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 2000; 355:712-715